Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers

Oncogene

Volumn 21-48, Issue 6, 2002, Pages 7435-7451

  Pfeifer, Gerd P ^a   Denissenko, Mikhail F ^b   Olivier, Magali ^c   Tretyakova, Natalia ^d   Hecht, Stephen S ^d   Hainaut, Pierre ^c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b SEQUENOM INC   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Carcinogens; Cigarette smoke; DNA damage; Lung cancer; p53

Indexed keywords

CARCINOGEN; NITROSAMINE; POLYCYCLIC AROMATIC COMPOUND; PROTEIN P53; TOBACCO SMOKE;

ARTICLE; CANCER RISK; CARCINOGENESIS; CPG ISLAND; DNA DAMAGE; GENE MUTATION; LIVER CELL CARCINOMA; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; SMOKING;

CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; GENES, P53; HUMANS; MUTATION; SMOKING; TOBACCO;

NICOTIANA TABACUM;

EID: 0037152628     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205803     Document Type: Article

References (143)

1. Armstrong RN. (1997). Comprehensive Toxicology: Biotransformation. Vol 3. Guengerich FP (ed). New York: Elsevier Science, pp. 307 - 327.
2. Arora A, Willhite C and Liebler D. (2001). Carcinogenesis, 22, 1173 - 1178.
3. Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H and Kasai H. (1997). Carcinogenesis, 18, 1763 - 1766.
4. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Sheilds PG and Harris CC. (1999). J. Pathol., 187, 8 - 18.
5. Besarati Nia A, Kleinjans JC and Van Schooten FJ. (2002a). Biomarkers, 7, 209 - 229.
6. Besarati Nia ABates SEPfeifer GP (2002b). Cancer Res., 62, (in press).
7. Bigger C, St John J, Yagi H, Jerina D and Dipple A. (1992). Proc. Natl. Acad. Sci. USA, 89, 368 - 372.
8. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA and Sidransky D. (1995). New Engl. J. Med., 332, 712 - 717.
9. Burchell B, McGurk K, Brierley C and Clarke D. (1997). Comprehensive Toxicology: Biotransformation. Vol 3. Guengerich FP (ed). New York: Elsevier Science, pp. 401 - 436.
10. Burney S, Caulfield J, Niles J, Wishnok J and Tannenbaum S. (1999). Mutation Res., 424, 37 - 49.
11. Carmical J, Zhang M, Nechev L, Harris C, Harris T and Lloyd R. (2000). Chem. Res. Toxicol., 13, 18 - 25.
12. Casale G, Singhal M, Bhattacharya S, Ramanathan R, Roberts K, Barbacci D, Zhao J, Jankowiak R, Gross M, Cavalieri E, Small G, Rennard S, Mumford J and Shen M. (2001). Chem. Res. Toxicol., 14, 192 - 201.
13. Castelao J, Yuan J, Skipper P, Tannenbaum S, Gago-Dominguez M, Crowder J, Ross R and Yu M. (2001). J. Natl. Cancer Inst., 93, 538 - 545.
14. Chao A, Thun M, Jacobs E, Henley S, Rodriguez C and Calle E. (2000). J. Natl. Cancer Inst., 92, 1888 - 1896.
15. Chen JX, Zheng Y, West M and Tang M-S. (1998). Cancer Res., 58, 2070 - 2075.
16. Chen R-H, Maher VM and McCormick JJ. (1990). Proc. Natl. Acad. Sci. USA, 87, 8680 - 8684.
17. Chepiga T, Morton M, Murphy P, Avalos J, Bombick B, Doolittle D, Borgerding M and Swauger J. (2000). Food Chem. Toxicol., 38, 949 - 962.
18. Chung F, Zhang L, Ocando J and Nath R. (1999). Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. Singer B and Bartsch H (eds). Lyon, France: International Agency for Research on Cancer, pp. 45 - 54.
19. Conney A. (1982). Cancer Res., 42, 4875 - 4917.
20. Culp S, Gaylor D, Sheldon W, Goldstein L and Beland F. (1998). Carcinogenesis, 19, 117 - 124.
21. Culp S, Roberts D, Talaska G, Lang N, Fu P, Lay Jr J, Teitel C, Snawder J, Von Tungeln L and Kadlubar F. (1997). Mutation Res., 378, 97 - 112.
22. Das A, Tan KS, Gopalakrishnan S, Waring MJ and Tomasz M. (1999). Chem. Biol., 6, 461 - 471.
23. Delclos K and Kadlubar F. (1997). Comprehensive Toxicology: Chemical Carcinogens and Anticarcinogens. 12th Edn. Bowden GT and Fischer SM (eds). pp. 141 - 170.
24. DeMarini DM, Landi S, Tian D, Hanley NM, Li X, Hu F, Roop BC, Mass MJ, Keohavong P, Gao W, Olivier M, Hainaut P and Mumford JL. (2001). Cancer Res., 61, 6679 - 6681.
25. Denissenko MF, Chen JX, Tang MS and Pfeifer GP. (1997). Proc. Natl. Acad. Sci. USA, 94, 3893 - 3898.
26. Denissenko MF, Pao A, Pfeifer GP and Tang M-S. (1998). Oncogene, 16, 1241 - 1247.
27. Denissenko MF, Pao A, Tang M-S and Pfeifer GP. (1996). Science, 274, 430 - 432.
28. Deutsch-Wenzel R, Brune H, Grimmer G, Dettbarn G and Misfield J. (1983). J. Natl. Cancer Inst., 71, 539 - 543.
29. Doll R. (1996). Br. Med. J., 52, 35 - 49.
30. Duffel M. (1997). Comprehensive Toxicology: Biotransformation. Vol 3. Guengerich FP (ed). New York: Elsevier Science, pp. 365 - 384.
31. Eisenstadt E, Warren AJ, Porter J, Atkins D and Miller JH. (1982). Proc. Natl. Acad. Sci. USA, 79, 1945 - 1949.
32. Feng Z, Hu W, Rom WN, Beland FA and Tang M-S. (2002). Biochemistry, 41, 6414 - 6421.
33. Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH and Hecht SS. (1991). Chem. Res. Toxicol., 4, 364 - 368.
34. Geacintov NE. (1986). Carcinogenesis, 7, 759 - 766.
35. Greenblatt MS, Bennett WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855 - 4878.
36. Guengerich F. (2001). Chem. Res. Toxicol., 14, 611 - 650.
37. Guengerich F and Kim D. (1991). Chem. Res. Toxicol., 4, 413 - 421.
38. Gupta R, Arif J and Gairola C. (1999). Mutation Res., 424, 195 - 205.
39. Hainaut P and Hollstein M. (2000). Adv. Cancer Res., 77, 81 - 137.
40. Hainaut P, Olivier M and Pfeifer GP. (2001). Mutagenesis, 16, 551 - 553.
41. Hainaut P and Pfeifer GP. (2001). Carcinogenesis, 22, 367 - 374.
42. Hanahan D and Weinberg R. (2000). Cell, 100, 57 - 70.
43. Harley N, Cohen B and Tso T. (1980). Banbury Report 3: A Safe Cigarette? Gori GB and Beck FG (eds). Cold Spring Harbor Laboratory, pp. 93 - 104.
44. Hecht S and Hoffmann D. (1988). Carcinogenesis, 9, 875 - 884.
45. Hecht S, Rivenson A, Braley J, DiBello J, Adams J and Hoffmann D. (1986). Cancer Res., 46, 4162 - 4166.
46. Hecht S and Tricker A. (1999). III. Analytical Determination of Nicotine and Related Compounds and Their Metabolites. Gorrod JW and Jacob P (eds). Amsterdam: Elsevier Science, pp. 421 - 488.
47. Hecht SS. (1998). Chem. Res. Toxicol., 11, 559 - 603.
48. Hecht SS. (1999). J. Natl. Cancer Inst., 91, 1194 - 1210.
49. Henderson P, Delaney J, Gu F, Tannenbaum S and Essigmann J. (2002). Biochemistry, 41, 914 - 921.
50. Hernandez-Boussard TM and Hainaut P. (1998). Environ. Health Perspect., 106, 385 - 391.
51. Hoeijmakers JH. (2001). Nature, 411, 366 - 374.
52. Hoffmann D and Hecht S. (1990). Handbook of Experimental Pharmacology. 94/1 Ed. Cooper CS and Grover PL (eds). Heidelberg: Springer-Verlag, pp. 63 - 102.
53. Hoffmann D, Hoffmann I and El-Bayoumy K. (2001). Chem. Res. Toxicol., 14, 767 - 790.
54. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49 - 53.
55. Husgafvel-Pursiainen K and Kannio A. (1996). Environ. Health Perspect., 104, (Suppl. 3): 553 - 556.
56. Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A and Harris CC. (2001). Cancer Res., 61, 6350 - 6355.
57. Hussain SP and Harris CC. (1998). Cancer Res., 58, 4023 - 4037.
58. International Agency for Research on Cancer. (1972). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 1. Lyon, France: IARC.
59. International Agency for Research on Cancer. (1973). IARC Monographs on the Carcinogenic Risk of Chemicals to Man. Vol 4. Lyon, France: IARC, pp. 127 - 136.
60. International Agency for Research on Cancer. (1974a). IARC Monographs on the Carcinogenic Risk of Chemicals to Man. Vol 7. Lyon, France: IARC, pp. 111 - 140.
61. International Agency for Research on Cancer. (1974b). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 4. Lyon, France: IARC, pp. 97 - 111.
62. International Agency for Research on Cancer. (1978). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 17. Lyon, France: IARC, pp. 83 - 124.
63. International Agency for Research on Cancer. (1982). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 29. Lyon, France: IARC, pp. 93 - 148.
64. International Agency for Research on Cancer. (1983). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 32. Lyon, France: IARC, pp. 211 - 224.
65. International Agency for Research on Cancer. (1985). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 36. Lyon, France: IARC, pp. 101 - 132.
66. International Agency for Research on Cancer. (1986a). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 60. Lyon, France: IARC, pp. 73 - 159.
67. International Agency for Research on Cancer. (1986b). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 38. Lyon, France: IARC, pp. 37 - 375.
68. International Agency for Research on Cancer. (1992). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 54. Lyon, France: IARC, pp. 237 - 285.
69. International Agency for Research on Cancer. (1999). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 71. Lyon, France: IARC, pp. 109 - 225.
70. Johnson RE, Prakash S and Prakash L. (1999). Science, 283, 1001 - 1004.
71. Koc H, Tretyakova N, Walker V, Henderson R and Swenberg J. (1999). Chem. Rev. Toxicol., 12, 566 - 574.
72. Koivisto P, Kilpelainen I, Rasanen I, Adler I, Pacchierotti F and Peltonen K. (1999). Carcinogenesis, 20, 1253 - 1259.
73. Kozack R, Seo K, Jelinsky S and Loechler E. (2000). Mutation Res., 450, 41 - 59.
74. Kriek E, Rojas M, Alexandrov K and Bartsch H. (1998). Mutation Res., 400, 215 - 231.
75. Kunkel T. (1984). Proc. Natl. Acad. Sci. USA, 81, 1494 - 1498.
76. Lin D, Lay JO, Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP and Kadlubar FF. (1994). Environ. Health Perspect., 102, (Suppl. 6): 11 - 16.
77. Livneh Z. (2001). J. Biol. Chem., 276, 25639 - 25642.
78. Loechler E, Green C and Essigmann J. (1984). Proc. Natl. Acad. Sci. USA, 81, 6271 - 6275.
79. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K and Hanaoka F. (1999). Nature, 399, 700 - 704.
80. Mazur M and Glickman B. (1988). Somat. Cell Mol. Genet., 14, 393 - 400.
81. McCoy G and Wynder E. (1979). Cancer Res., 39, 2844 - 2850.
82. Melchior Jr W, Marques M and Beland F. (1994). Carcinogenesis, 15, 889 - 899.
83. Melikian A, Amin S, Huie K, Hecht S and Harvey R. (1988). Cancer Res., 48, 1781 - 1787.
84. Melikian A, Fudem Goldin B, Prahalad A and Hecht S. (1990). Chem. Res. Toxicol., 3, 139 - 143.
85. Miller J. (1994). Drug Metabol. Dispos., 26, 1 - 36.
86. Misra R, Page J, Smith G, Waalkes M and Dipple A. (1998). Chem. Res. Toxicol., 11, 211 - 216.
87. Moriya M. (1993). Proc. Natl. Acad. Sci. USA, 90, 1122 - 1126.
88. Nair J, Barbin A, Velic I and Bartsch H. (1999). Mutation Res., 424, 59 - 69.
89. 1 Mice (Gavage Studies). National Toxicology Program.
90. Nesnow S, Ross J, Stoner G and Mass M. (1995). Toxicology. 103, 403 - 413.
91. Noori P and Hou S. (2001). Carcinogenesis, 22, 1825 - 1830.
92. Ory K, Legros Y, Auguin C and Soussi T. (1994). EMBO J., 13, 3496 - 3504.
93. Paschke T. (2000). Mutagenesis, 15, 457 - 458.
94. Pauly GT, Peterson LA and Moschel RC. (2002). Chem. Res. Toxicol., 15, 165 - 169.
95. Penning T, Burczynski M, Hung C, McCoull K, Palackal N and Tsuruda L. (1999). Chem. Res. Toxicol., 12, 1 - 18.
96. Pfeifer GP. (2000). Mutat. Res., 450, 155 - 166.
97. Pfeifer GP and Denissenko MF. (1998). Environ. Mol. Mutagen., 31, 197 - 205.
98. Phillips DH. (1983). Nature, 303, 468 - 472.
99. Preussmann R and Stewart B. (1984). Chemical Carcinogens. 2nd Ed. Vol 2. ACS Monograph 182. Searle CE (ed). Washington, DC: American Chemical Society, pp. 643 - 828.
100. Proctor RN. (2001). Nature Reviews Cancer, 1, 82 - 86.
101. Pryor W. (1997). Environ. Health Perspect., 105, 875 - 882.
102. Recio L, Saranko C and Steen A. (2000). Res. Rep. Health Eff. Inst. 49 - 87.
103. Reznik-Shuller H. (1983). Comparative Respiratory Tract-Carcinogens. 2nd Edn. Reznik-Shuller HM (ed). Boca Raton, FL: CRC Press, pp. 109 - 159.
104. Rivenson A, Hoffmann D, Prokopczyk B, Amin S and Hecht S. (1988). Cancer Res., 48, 6912 - 6917.
105. Rodin SN and Rodin AS. (2000). Proc. Natl. Acad. Sci. USA, 97, 12244 - 12249.
106. Rojas M, Alexandrov K, Cascarbi I, Brockmoller J, Likhachev A, Pozharisski K, Bouvier G, Auburtin G, Mayer L, Koop-Schneider A, Roots I and Bartsch H. (1998). Pharmacogenetics, 8, 109 - 118.
107. Ronai ZA, Gradia S, Peterson LA and Hecht SS. (1993). Carcinogenesis, 14, 2419 - 2422.
108. Ross J and Nesnow S. (1999). Mutation Res., 424, 155 - 166.
109. Rubin H. (2001). Carcinogenesis, 22, 1903 - 1930.
110. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T and Klein-Szanto AJP. (1993). Proc. Natl. Acad. Sci. USA, 90, 1013 - 1017.
111. Santella R. (1999). Cancer Epidemiol. Biomarkers Prev., 8, 733 - 739.
112. Schüller H, Jorquera R, Reichert A and Castonguay A. (1993). Cancer Res., 53, 2498 - 2501.
113. Sellakumar A and Shubik P. (1974). J. Natl. Cancer Inst., 53, 1713 - 1719.
114. Seo K, Jelinsky S and Loechler E. (2000). Mutation Res., 463, 215 - 246.
115. Singer B and Grunberger D. (1983). Molecular Biology of Mutagens and Carcinogens. New York: Plenum Press, pp. 45 - 94.
116. Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, Tang M-S and Pfeifer GP. (2000). J. Natl. Cancer Inst., 92, 803 - 811.
117. Snook M, Severson R, Arrendale R, Higman H and Chortyk O. (1978). Beiträge Tabakforsch., 9, 222 - 247.
118. Sodum R and Fiala E. (1998). Chem. Res. Toxicol., 11, 1453 - 1459.
119. Solt D, Polverini P and Claderon L. (1987). J. Oral Path., 16, 294 - 302.
120. Spiegelhalder B and Bartsch H. (1996). Eur. J. Cancer Prev., 5, 33 - 38.
121. Swenberg J, Bogdanffy M, Ham A, Holt S, Kim A, Morinello E, Ranasinghe A, Scheller N and Upton P. (1999). IARC Sci. Publ., 29 - 43.
122. Swenberg J, Kerns W, Mitchell R, Gralla J and Pavkov K. (1980). Cancer Res., 40, 3398 - 3402.
123. Szeliga J and Dipple A. (1998). Chem. Res. Toxicol., 11, 1 - 11.
124. Tang D, Phillips D, Stampfer M, Mooney L, Hsu Y, Cho S, Tsai W, Ma J, Cole K, She M and Perera F. (2001). Cancer Res., 61, 6708 - 6712.
125. Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith Jr WC and Henderson RF. (1995). Carcinogenesis, 16, 1723 - 1731.
126. Tornaletti S and Pfeifer GP. (1995). Oncogene, 10, 1493 - 1499.
127. Tretyakova N, Lin Y, Sangaiah R, Upton P and Swenberg J. (1997). Carcinogenesis, 18, 137 - 147.
128. Vähäkangas KH, Bennett WP, Castrén K, Welsh JA, Khan MA, Blömeke B, Alavanja MC and Harris CC. (2001). Cancer Res, 61, 4350 - 4356.
129. Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly A, Golka K, Okkels H, Risch A, Rothman N, Sim E and Taioli E. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 1249 - 1252.
130. Walker DR, Bond JP, Tarone RE, Harris CC, Makalowski W, Boguski MS and Greenblatt MS. (1999). Oncogene, 18, 211 - 218.
131. Wang M, McIntee E, Cheng G, Shi X, Villalta P and Hecht S. (2000a). Chem. Res. Toxicol., 13, 1149 - 1157.
132. Wang M, McIntee E, Cheng G, Shi Y, Villalta P and Hecht S. (2000b). Chem. Res. Toxicol., 13, 1065 - 1074.
133. Wang M, McIntee E, Cheng G, Shi Y, Villalta P and Hecht S. (2001a). Chem. Res. Toxicol., 14, 423 - 430.
134. Wang M, McIntee E, Shi Y, Cheng G, Upadhyaya P, Villalta P and Hecht S. (2001b). Chem. Res. Toxicol., 14, 1435 - 1445.
135. Wei SJ, Chang RL, Bhachech N, Cui XX, Merkler KA, Wong CQ, Hennig E, Yagi H, Jerina DM and Conney AH. (1993). Cancer Res., 53, 3294 - 3301.
136. Weisenberger DJ and Romano LJ. (1999). J. Biol. Chem., 274, 23948 - 23955.
137. Wilson VL, Weston A, Manchester DK, Trivers GE, Roberts DW, Kadlubar FF, Wild CP, Montesano R, Willey JC and Mann DL. (1989). Carcinogenesis, 10, 2149 - 2153.
138. Witschi H. (2000). Exp. Lung Res., 26, 743 - 755.
139. World Health Organization. (1997). Tobacco or Health: A Global Status Report. Geneva: WHO, pp. 10 - 48.
140. Yoon JH, Smith LE, Feng Z, Tang M, Lee CS and Pfeifer GP. (2001). Cancer Res., 61, 7110 - 7117.
141. Zhang Y, Yuan F, Wu X, Rechkoblit O, Taylor JS, Geacintov NE and Wang Z. (2000). Nucleic Acids Res., 28, 4717 - 4724.
142. Zhao C, Tyndyk M, Eide I and Hemminki K. (1999). Mutation Res., 424, 117 - 125.
143. Zhao C, Vodicka P, Sram R and Hemminki K. (2000). Carcinogenesis, 21, 107 - 111.